Anti-TRHDE/ PAP-II/ PGPEP2 monoclonal antibody

Anti-TRHDE/ PAP-II/ PGPEP2 antibody for FACS & in-vivo assay

Target products collectionGo to TRHDE/TRHDE products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1877-Ab-1/ GM-Tg-hg-MP1877-Ab-2Anti-Human TRHDE monoclonal antibodyHuman
GM-Tg-rg-MP1877-Ab-1/ GM-Tg-rg-MP1877-Ab-2Anti-Rat TRHDE monoclonal antibodyRat
GM-Tg-mg-MP1877-Ab-1/ GM-Tg-mg-MP1877-Ab-2Anti-Mouse TRHDE monoclonal antibodyMouse
GM-Tg-cynog-MP1877-Ab-1/ GM-Tg-cynog-MP1877-Ab-2Anti-Cynomolgus/ Rhesus macaque TRHDE monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1877-Ab-1/ GM-Tg-felg-MP1877-Ab-2Anti-Feline TRHDE monoclonal antibodyFeline
GM-Tg-cang-MP1877-Ab-1/ GM-Tg-cang-MP1877-Ab-2Anti-Canine TRHDE monoclonal antibodyCanine
GM-Tg-bovg-MP1877-Ab-1/ GM-Tg-bovg-MP1877-Ab-2Anti-Bovine TRHDE monoclonal antibodyBovine
GM-Tg-equg-MP1877-Ab-1/ GM-Tg-equg-MP1877-Ab-2Anti-Equine TRHDE monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1877-Ab-1/ GM-Tg-hg-MP1877-Ab-2; GM-Tg-rg-MP1877-Ab-1/ GM-Tg-rg-MP1877-Ab-2;
GM-Tg-mg-MP1877-Ab-1/ GM-Tg-mg-MP1877-Ab-2; GM-Tg-cynog-MP1877-Ab-1/ GM-Tg-cynog-MP1877-Ab-2;
GM-Tg-felg-MP1877-Ab-1/ GM-Tg-felg-MP1877-Ab-2; GM-Tg-cang-MP1877-Ab-1/ GM-Tg-cang-MP1877-Ab-2;
GM-Tg-bovg-MP1877-Ab-1/ GM-Tg-bovg-MP1877-Ab-2; GM-Tg-equg-MP1877-Ab-1/ GM-Tg-equg-MP1877-Ab-2
Products NameAnti-TRHDE monoclonal antibody
Formatmab
Target NameTRHDE
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-TRHDE benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species TRHDE/ PAP-II/ PGPEP2 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP1877
    Target NameTRHDE
    Gene ID29953,237553,366894,717653,481166,101085556,100336818,100057250
    Gene Symbol and Synonyms9330155P21Rik,PAP-II,PGPEP2,TRH-DE,TRHDE
    Uniprot AccessionQ9UKU6,Q10836
    Uniprot Entry NameTRHDE_HUMAN,TRHDE_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000072657
    Target ClassificationN/A

    The target: TRHDE, gene name: TRHDE, also named as PAP-II, PGPEP2, TRH-DE. This gene encodes a member of the peptidase M1 family. The encoded protein is an extracellular peptidase that specifically cleaves and inactivates the neuropeptide thyrotropin-releasing hormone.[provided by RefSeq, Dec 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.